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Breast cancera b s t r a c t
Interoperability across data sets is a key challenge for quantitative histopathological imaging. There is a
need for an ontology that can support effective merging of pathological image data with associated clin-
ical and demographic data. To foster organized, cross-disciplinary, information-driven collaborations in
the pathological imaging field, we propose to develop an ontology to represent imaging data and meth-
ods used in pathological imaging and analysis, and call it Quantitative Histopathological Imaging
Ontology – QHIO. We apply QHIO to breast cancer hot-spot detection with the goal of enhancing reliabil-
ity of detection by promoting the sharing of data between image analysts.
 2016 Elsevier Inc. All rights reserved.1. Introduction
Interoperability across data sets is a key challenge for quantita-
tive histopathological imaging (QHI). Interoperability describes the
extent to which systems and devices can share data and interpret
the data that is shared. The ideal is for multiple systems to be able
to use and interpret each other’s data in just the same way that
they can use and interpret their own data. Limited interoperability
between imaging data systems is a major obstacle to coherent
multi-institutional collaboration, in digital pathology as in many
other areas.
Interoperability, according to the HIMSS Dictionary, may be
seen on three different levels.1 At the foundational level interoper-
ability describes the capability for simple data exchange from one
information system to another, without any requirement for the
receiving information technology system to be able to interpret
the data that it receives. Interoperability at the structural level refers
to the capability for data exchange in which the format and organi-
zation of the data is preserved unaltered. Here interoperabilityrelates to the syntax of the data exchanged. The highest level, that
of semantic interoperability, is achieved according to the HIMSS Dic-
tionary when data systems can take advantage ‘‘of both the structur-
ing of the data exchange and the codification of the data including
vocabulary so that the receiving information technology systems
can interpret the data.”
Many strategies to achieve semantic interoperability nowadays
require the use of controlled vocabularies which provide single
annotations or tags to be used to address the problems which arise
when multiple coding systems use different codes describe the
same entities in reality. ‘‘Ontologies” improve on controlled vocab-
ularies by using links and logical definitions to connect terms in a
rich network of well-defined relationships. With the advance of
pathological imaging technology and of associated software for
the processing of pathological images, the need arises for an ontol-
ogy which can support effective merging of pathological image
data with associated clinical and demographic data that have
already been described using existing controlled vocabularies such
as SNOMED-CT, the NCI Thesaurus, or the ontologies such as the
Cell Ontology constituting the OBO Foundry [1].
To this end we are constructing a Quantitative Histopathological
Image Ontology (QHIO) incorporating terms representing the differ-
ent types and subtypes of pathological images, imaging processes
and techniques, and computational algorithms. In addition the ontol-
ogy will incorporate formal definitions of these terms and specify
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sponding types. Because QHIO will itself follow the principles of
the OBO Foundry, the data resulting from the use of QHIO terms
in annotations will be in a form that allows integration with other
commonly used ontologies in the biomedical domain.
The result will allow us to leverage the opportunities brought
by new imaging platforms and algorithms to create an environ-
ment in which the clinical imaging data, and clinician and algorith-
mically created annotations deriving from different communities
of clinicians and scientists, can be combined and analyzed as a sin-
gle whole.2. The problem of reproducibility of image analysis
A further urgent factor in contemporary research is the issue of
reproducibility of clinical and scientific findings. The reproducibil-
ity and validation of large-scale, cross-institutional imaging
research is limited by the fact that there is lacking any common
structured framework for describing images and the results of their
analysis. Here, too, we believe, ontologies can play a role by provid-
ing controlled vocabularies which can be used to describe in stan-
dardized ways the steps taken to achieve particular results [2].
Currently, pathology image data is collected in local ‘‘silos” using
in-house protocols, and is processed using proprietary algorithms
developed in isolation. Typically the software itself may be
unavailable to downstream image consumers, and even when it
is available, there is rarely information about the sets of parame-
ters necessary to run the software. Even the type of outputs of
these algorithms, for example, a new potential prognostic feature,
is not open to discovery by third party software. For these and a
series of related reasons digital histopathology is difficult to repro-
duce and validate. While reproducibility and validation are impor-
tant goals in their own right, even more value can be gained by
combining and building upon image data and software methods
across institutions.3. Quantitative Histopathological Imaging Ontology (QHIO)
To foster organized, cross-disciplinary, information-driven col-
laborations in the pathological imaging field, we propose to
develop an ontology to represent imaging data and methods used
in pathological imaging and analysis with an initial focus on
enabling effective communication and collaboration between
developers of algorithms for analyzing histopathology images.
Our ontology is modeled after the Gene Ontology (GO) [3] and fol-
lows the principles of the Open Biomedical Ontologies (OBO) Foun-
dry [4], principles now used by some dozens of ontology-driven
research efforts in clinical and translational science. An essential
aspect of our work is the reuse of existing ontology terms wherever
possible, thereby increasing the potential for interoperability as
well as reducing the effort involved in defining new terms [5].
Hereafter when we refer to QHIO we mean the aggregate of terms
we define, together with those terms that have been reused
(imported) from other ontologies [5].
We intend to continue to extend and use QHIO to promote long-
term interoperability of data across pathology imaging. We will
cultivate wide community dissemination through development
of model collections that include sample image data, example soft-
ware that can compute useful information about them as well as
the annotated output of this software. Both the model collections
and the ontology will be released into the public domain, again fol-
lowing the model of the GO [4].
The workflow in histopathology-based clinical testing extends
from biopsy collection, to slide production and analysis, to the
assignment of a diagnostic category, to the creation of a predictivestatement for an individual patient based on that diagnostic cate-
gory. All of these activities combine to support the choice of a
treatment plan by a clinician for a particular patient.
At the same time these activities cover a variety of different
domains and thus they raise multiple questions that will impact
interoperability. Some of these questions include: How are demo-
graphic, anatomical and relevant health information to be gathered
and communicated? How are annotations for histology image data
to be created and what will they identify? What information will
be needed to enable productive communication between image
analysis researchers and clinicians? Answers to these questions
will influence the success and quality of interoperability. Our
long-term goal is to demonstrate that an ontology can enable inter-
operability in the pathology image domain. To achieve this goal,
we are in the process of curating an annotated dataset and devel-
oping parallel sets of algorithms for quantifying breast cancer
histopathology. We will record the results of running different
combinations of these algorithms on the same dataset as a test
of their utility, while at the same time developing and testing QHIO
itself.
QHIO’s overarching goal is to foster interoperability of compu-
tationally derived image data. We need to emphasize that this
study is not designed so much to help routine clinical diagnosis;
rather it is designed to create an enriched data resource in which
various kinds of clinical and translational software approaches
can be tested out. It can also be used to explore the role image data
may play in clinical decision support systems and to test hypothe-
ses regarding correlations between image features and patient out-
comes, or between image features and other features catalogued
by OBO Foundry ontologies.4. Motivating examples
We present two general activities (i.e. validation and combining
multiple analyses to make diagnoses), and give a more detailed use
case – the hot spot detection problem – that motivates our effort.4.1. Activity 1: Validation
The issue of interoperability is a major concern in validation.
For example, two groups working on feature extraction may be
investigating different but overlapping features, but currently have
no way to develop a comparison tool to use their extracted features
on the same dataset and thus produce quantitative results in a
manner that can be easily communicated. This is important
because such comparison is not only important for the qualitative
validation of subject matter experts’ prognoses but also for timely
identification of divergence of results flowing from use of indepen-
dently developed algorithms targeting the same object.4.2. Activity 2: Combining multiple analyses to make diagnoses
Another scenario where QHIO might be useful is in the making
of diagnoses on the basis of data derived from multiple analyses.
Several different algorithms can be run on the same images to
analyse different aspects (e.g. the amount of stroma and mitotic
count). A diagnostic program needs to check whether the available
data have the specific features it needs: relative amounts of cells by
type, quantity of mitotic cells, and potentially a subgroup of those
within certain regions. It is important that we can establish effec-
tively that these features are among those found in several differ-
ent analyses while the algorithm determines the case, retrieves the
relevant information, and computes the diagnostic in a robust
manner.
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Ki67, a nuclear marker expressed in all phases of the cell cycle
except G0 [6], has been widely used in pathology to assess prolif-
eration within multiple neoplasms. ‘‘Hot Spots”, are areas with
prevalent Ki67 staining with the highest number of positively
staining nuclei within the invasive component. In the literature,
there is no uniform approach to scoring hot spots. Many studies
have specifically targeted hot spots in determining the Ki67 index
while others have done an overall assessment of Ki67 with the
incorporation of the hot spots in the overall index. Clearly, studies
addressing outcome with detailed hot spot scoring are warranted.
However in order to do better we need to develop an automatic hot
spot detection method that can minimize the intra- and inter-
pathologist variability in identification of hot spots.
In previous work, we developed a hot spot tool [7] for breast
cancer as Ki67 has shown promise as a prognostic marker and pre-
dictor of responsiveness to chemotherapy or endocrine therapy.
The method first segments Ki67 positive pixels using a
previously-developed Visually Meaningful Segmentation (VMS)
method [8]. VMS generates an image-dependent filter, which in
turn generates a density map from the segmented image. The
smoothness of the density image simplifies the detection of local
maxima, which directly correspond to the hot spots in the image.
The method was tested on 23 different regions of interest extracted
from 10 breast cancer Ki67 slide images. To determine intra-reader
variability, each image was annotated twice for hot spots by a
board-certified pathologist with a two-week interval between the
two readings. A computer-generated hot spot was considered
true-positive if it agreed with either of the two annotation sets pro-
vided by the pathologist. While intra-reader variability was 57%,
our method correctly detected hot spots with 81% precision. In
order to run this tool at multiple institutions, some interoperability
issues need to be overcome. For instance, we need a way to identify
the stain type as Ki67. Additionally, several terms need to be
defined and communicated, for example, positive and negative
stain, hot spot boundary, image magnification, etc., both to the
algorithm as well as the pathologist who will use this system.5. Methods
In our paper ‘‘Biomedical imaging ontologies: A survey and pro-
posal for future work” [9] we surveyed the state of the art as con-
cerns the development and application of controlled vocabularies
and ontologies for digital pathology [10,11]. We also laid out a plan
for building QHIO and for using QHIO in promoting the sharing of
pathology image data and associated algorithm and algorithm out-
put information. We have begun to execute this plan by
1. creating a prototype of QHIO and
2. applying it to breast cancer hot-spot detection with the goal of
enhancing reliability of detection by promoting the sharing of
data between image analysts.
Our goal here is to demonstrate that QHIO can be used for
pathology data sharing, and that it can serve as a starting point
for further development toward realizing our longer term goals
of advancing interoperability of histopathological imaging systems
and reproducibility of histopathological imaging assays. The cur-
rent version of QHIO is available at https://github.com/ontodev/
QHIO.
A turning point in the development of ontologies and their
extensive use in biology and biomedicine was the building and
application of the Gene Ontology (GO) [3]. That work showed the
benefits of tagging sequence data obtained from both humansand multiple model organism species with a single set of
species-neutral terms. The success of the GO created a situation
in which many biomedical subdisciplines saw a need to develop
ontologies of their own, often in uncoordinated fashion with resul-
tant tendencies to forking and redundancy. To counteract these
tendencies a group of researchers developing ontologies centered
on the GO established, in 2004, the Open Biomedical Ontology
(OBO) Foundry initiative, promulgating a set of principles for
ontology development which have been tested in practice and
refined in light of the lessons learned by the many groups who
have since sought to apply them in their work. It is these principles
which we have used also to guide our work on QHIO. Chief among
them is a commitment by the developers of each ontology to
ensure interoperability with its neighbouring ontologies.5.1. The Ontology for Biomedical Investigations
One neighbour to QHIO is the Ontology for Biomedical Investi-
gations (OBI), an OBO Foundry ontology with over 2500 terms for
describing biomedical investigations, including core terms such
as investigation, assay, planning, protocol, specimen, and conclusion
based on data.
Currently, OBI contains a small number of terms for medical
imaging and pathology, including terms such as imaging assay,
staining, feature extraction, and pathologist role. We are developing
QHIO as an extension of OBI, with the immediate advantage of
interoperability between QHIO and the larger OBO ecosystem.
QHIO will be subject to the same processes of ongoing review
and maintenance and be able to draw on the deep expertise that
the OBI community has developed over several years.
OBI’s hierarchy of terms can be used to represent investigations
either in great detail or in broad strokes, as appropriate. For exam-
ple, OBI can be used to annotate a given body of experiment
records along dimensions such as: funding agency, antibodies,
staining methods, statistical algorithms used, and so forth. In this
way OBI enables powerful querying across experimental data,
made still more powerful through cross-linkage to other OBO
Foundry ontologies such as the Gene Ontology, the Cell Ontology
(CL) [12], the Foundational Model of Anatomy (FMA) [13], the
Human Disease Ontology [14], Chemical Entities of Biological
Interest (ChEBI) ontology [15], as well as to external ontology
resources including – most importantly for our purposes – the
National Cancer Institute Thesaurus (NCIT). This enables other
researchers to find experimental data that have been annotated
with OBI because they know which terms to look for when search-
ing. It also enables other researchers to understand how the data
was acquired, since OBI enables provenance information pertain-
ing not only to the persons, organizations, places and times of gen-
eration of the data, but also the experimental and data processing
methods used.
A number of initiatives are under way to map these and other
OBO Foundry ontologies to major clinical vocabularies (especially
SNOMED CT and ICD) in order to allow them to be used for query-
ing and analytical purposes in tandem with Electronic Health
Record and other clinical data [16]. We will take this work further
in the specific field of breast cancer research, taking account of the
set of common data elements (CDEs) recommended by the NCI’s
Early Detection Research Network (EDRN) for the treatment of
breast cancer biomarker data. We will explore applications of our
work to the creation of CDEs for cancer imaging biomarkers, draw-
ing also on the preliminary work performed within the framework
of the Quantitative Imaging Biomarker Ontology (QIBO) project
[17].
Fig. 1. From specimen to hot spot detection. Overview of types and relationships in QHIO. Types are taken from OBI. More specific types from QHIO noted after colon.
Fig. 2. Sample workflow represented through QHIO and OBI terms. (PCA = Principal Component Analysis).
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Currently whole slide pathology images are annotated using
vendor-supplied, freely available software programs. The resultant
annotations in these programs typically employ natural language
phrases, sometimes using machine-readable formats such as
XML. They are limited to small controlled vocabularies of terms
for colors and basic geometrical shapes (e.g. lines, circles, free-
form figures), and use unstructured text fields to describe features
of interest (e.g. ‘necrotic region’, ‘necrosis’, etc.). Annotations cre-
ated by members of given communities using given vendor soft-
ware are in almost every case incompatible with those created
by other communities using other software. This locks valuable
data into information silos.
The challenges of sharing algorithms and image features are
even greater than those of sharing image annotations because no
standards currently exist to describe algorithms and image fea-
tures. To rectify this problem QHIO will include standard terms
not merely for algorithm and feature types and attributes but alsofor all other entities involved in each stage of the pathological
imaging and analysis workflow (Fig. 1). These will include:
1. Input: type (e.g. image), preparation processes such as staining,
slide characteristics, magnification, resolution, the meaning and
typical range of parameters and other annotations.
2. Parameters: size of the filter window sizes, the number of iter-
ations, etc.
3. Output: type (e.g. image, measurement), the meaning and typ-
ical range of parameters, statistical details (e.g. accuracy, false
positive rate), statistical evaluation methodology (e.g. ROC)
and the methods/software required.
4. Execution: operating system (e.g. Windows 7), software envi-
ronment (e.g. Matlab), required resources (e.g. RAM, storage),
expected time to run the algorithm.
In addition there is a need to improve the existing annotation
scheme by using QHIO in tandem with standard linked data for-
mats that generalize current approaches based on XML, by
Table 1
Hot spot detection algorithm related terms, existing OBO superclass and URI, and upper level term. Information entity is from the IAO, disorder from OGMS, and rest of the terms
are from BFO.
Term needed Mid-level parent Identifier High-level parent
1 Color space transformation Data transformation OBI_0200000 Process
2 Image segmentation Biological feature identification OBI_0000015 Process
3 Object classification Class discovery data transformation OBI_0200175 Process
4 Clustering Class discovery data transformation OBI_0200175 Process
5 Pixel Unit UO_0000000 Information entity
6 Image markup Symbol IAO_0000028 Information entity
7 Image annotation Textual entity IAO_0000300 Information entity
8 Histological slide scanning Image creation OBI_0001007 Process
9 Histological slide scanner Image creation device OBI_0000398 Material entity
10 Image region Part_of some image IAO_0000101 Information entity
11 Histological mounting Histological sample preparation OBI_0000341 Process
12 Ischemia Ischemia DOID_326 Disorder
13 Tissue dehydration Material processing OBI_0000094 Process
14 Histological sectioning Histological sample preparation OBI_0000341 Process
15 Optical magnification ratio Device setting OBI_0000654 Quality
16 Microns per pixel Unit label UO_0000000 Information entity
17 Image annotation creation Documenting IAO_0000572 Process
18 Histological slide Microscope slide OBI_0400170 Material entity
19 Ki67 stain Cytological stain role OBI_0000026 Material entity
20 Ki67 Antigen Ki-67 PR_000010425 Material entity
21 Hot spot Cellular feature identification OBI_0000219 Information entity
22 Histological section Tissue specimen OBI_0001479 Material entity
23 Mitosis count Substance unit UO_0000006 Information entity
24 Ki67 percentage Concentration unit UO_0000051 Information entity
Fig. 3. An example representation in the QHIO prototype generated using Protégé.
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rithm annotations cleanly interoperable between sites (Fig. 2).
For this study, we have identified hot spot detection algorithm-
related terms (Table 1). These terms as well as ontological terms
necessary to represent images were included in the QHIO proto-
type (Fig. 3).6. Discussion and conclusion
Experience shows that – even with the use of traditional Delphi
techniques [18] – current image annotation formats and current
ways of creating annotations (in many cases on the basis of free
text or locally developed codes) leave much of the data accessible
only at the site where it was created. Such data is both difficult to
interpret and understand outside that context, and is in practice
thus undiscoverable by external researchers. Our future work will
be about bridging that gap by building an ontology and supporting
software for better data sharing.
The potential value of QHIO is its ability to aggregate data from
multiple sources that can then be subject to analysis for research
purposes. Establishing which images are compatible with a chosen
algorithm and which might be pooled in an aggregate analysis cer-
tainly could benefit researchers, and the provision of correspond-
ing information in the QHIO would be very valuable for this
purpose, whether embedded in the image metadata or in the data-
base from which they are derived. Using a subset of the common
dataset, ontology development experts need to continue the devel-
opment of QHIO. QHIO must be applied to convert the annotated
image data into a set of interoperable, standardized data resources,
supported by tools that allow for rich search and analysis, and
automated matching of algorithms to appropriate input data.
Ontologies serve as crucial aids to human communication, and
are supported by a range of technologies that aid machine commu-
nication, search, and analysis [19]. We will use linked data stan-
dards developed by the World Wide Web Consortium (W3C) and
associated technologies to build, maintain and use QHIO, and to
process, store, and query annotations on images and algorithms.
In particular the W3C standard Web Ontology Language (OWL)
[20] will serve as the foundational technology for QHIO, as it is
for all OBO ontologies. OWL brings both the ability to define and
organize the classes in the ontology and the ability to instantiate
those classes in the case of particular workflows or studies. OWL
builds on the Resource Description Framework (RDF), which can
be queried using the SPARQL Query Language. These and other
software resources used in our project are based on open source
tools and libraries. We have already demonstrated the use of
OWL in QHIO, and used it to model the application of a hot-spot
detection algorithm.
QHIO will also build upon existing work done by the Open
Microscopy Environment project (http://www.openmicroscopy.
org/site/support/ome-model/). For example, OME already deals
very effectively with the details of various file formats. QHIO and
OME are complementary efforts. One future research direction is
to establish tight integration between OME and QHIO, although
this may require changes to both OME and QHIO. Additionally,
we need to supply resources for keeping track of the image artifact
itself, of how it changes as different sorts of annotations are added.
We will use QHIO and linked data tools to develop an auto-
mated workflow for converting existing image annotations in our
common dataset to linked data annotations using QHIO terms
and terms from associated ontologies and structured resources ref-
erencing clinical data. The converted data will be loaded into an
RDF database where it can be shared and queried using SPARQL.
It is at this point the benefits of using OBO Foundry ontologies
become increasingly clear: Every ontology term belongs to a hierarchy of more-and-less
general terms, allowing for queries at many levels of specificity.
 Ontology terms are defined through logical axioms that provide
further links across the network of data, such as parthood,
aboutness, adjacency, inclusion and other relations.
 The logic of OWL allows for automated reasoning software to
infer further links in the network from existing links and logical
axioms, facilitating error checking and discovery of new
knowledge.
 Pathology imaging data can be easily integrated with data from
other medical and scientific domains.
The technology that is involved is now widely dispersed
through the biomedical research community through the sus-
tained support not merely of the W3C [20] but also of the National
Cancer Institute, the International Health Terminology Standards
Development Organization (IHTSDO, now responsible for SNOMED
– CT) and by other bodies.Funding
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